Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Multiple Sclerosis

Free Subscription 02.01.2023 1 J Neurol 1 J Neurol Neurosurg Psychiatry 1 Mult Scler 1 Nat Med 2 Neurology 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Neurol

1. PENNINGTON P, Weinstock-Guttman B, Kolb C, Jakimovski D, et al
   Correction to: Communicating the relevance of neurodegeneration and brain atrophy to multiple sclerosis patients: patient, provider and researcher perspectives.
   J Neurol. 2022 Dec 27. doi: 10.1007/s00415-022-11540.
   PubMed        
   
   

   
   J Neurol Neurosurg Psychiatry

2. VAN KEMPEN ZLE, Stalman EW, Steenhuis M, Kummer LYL, et al
   SARS-CoV-2 omicron breakthrough infections in patients with multiple sclerosis.
   J Neurol Neurosurg Psychiatry. 2022 Dec 23:jnnp-2022-330100.
   PubMed         Abstract available
   
   

   
   Mult Scler

3. BLOCK VJ, Cheng S, Juwono J, Cuneo R, et al
   Association of daily physical activity with brain volumes and cervical spinal cord areas in multiple sclerosis.
   Mult Scler. 2022 Dec 27:13524585221143726. doi: 10.1177/13524585221143726.
   PubMed         Abstract available
   
   

   
   Nat Med

4. O'LEARY K
   Mounting evidence for EBV links to multiple sclerosis.
   Nat Med. 2022;28:2450.
   PubMed        
   
   

   
   Neurology

5. BORDEA E, Hunter RM
   Excess Treatment Costs of Multiple Sclerosis: What Can We Learn From Longitudinal Population-Based Data?
   Neurology. 2022 Dec 23:10.1212/WNL.0000000000206804.
   PubMed        
   
   
6. GAVOILLE A, Rollot F, Casey R, Debouverie M, et al
   Investigating the Long-term Effect of Pregnancy on the Course of Multiple Sclerosis Using Causal Inference.
   Neurology. 2022 Dec 23:10.1212/WNL.0000000000206774.
   PubMed         Abstract available
   
   

   
   Proc Natl Acad Sci U S A

7. JANOSCHKA C, Lindner M, Koppers N, Starost L, et al
   Enhanced pathogenicity of Th17 cells due to natalizumab treatment: Implications for MS disease rebound.
   Proc Natl Acad Sci U S A. 2023;120:e2209944120.
   PubMed         Abstract available
   
   

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: